Wanjia Group Holdings Limited provided earnings guidance for the year ending March 31, 2015. The increase in forecast revenue generated from pharmaceutical retail chain business for the year ending 31 March 2015 changes from 14% to 8%. The projected growth rate for the remaining Forecast Period remains at approximately 10% per year which is consistent with the mild inflation in the PRC.

The forecast revenue generated from pharmaceutical wholesale and distribution business changes from a compound annual increase of approximately 12% during the Forecast Period to a decrease of approximately 30% for the year ending March 31, 2015, an increase of 5% in year ending 31 March 2016 and with stable increment of approximately 10% for the remaining Forecast Period.